Comment
doi: 10.1126/scitranslmed.aad7661.
Is all cancer therapy immunotherapy?
Affiliations
- PMID: 26606965
- DOI: 10.1126/scitranslmed.aad7661
Item in Clipboard
Comment
Is all cancer therapy immunotherapy?
Sci Transl Med.
.
Abstract
Researchers must renew efforts to decipher how standard chemotherapies enhance the effects of targeted immunotherapeutic agents (Müller et al., this issue).
Copyright © 2015, American Association for the Advancement of Science.
Comment on
-
Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade.Sci Transl Med. 2015 Nov 25;7(315):315ra188. doi: 10.1126/scitranslmed.aac4925. Sci Transl Med. 2015. PMID: 26606967
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
